Nissan Motor Co. (OTC: NSANY) is reportedly planning to shift part of its Rogue SUV production from Japan to the United States in response to escalating trade tensions under President Donald Trump’s tariff policies, according to Japan’s Nikkei newspaper.
The move could begin as early as this summer, with production at Nissan’s Fukuoka plant in western Japan expected to decrease. The company aims to relocate some manufacturing of the U.S.-bound Rogue SUV to its existing facility in Smyrna, Tennessee. This shift is intended to offset the growing cost impact of tariffs on Japanese exports to the U.S.
The Rogue, a top-selling model for Nissan in the American market, is currently built in both Japan and the U.S. The company had previously planned to reduce one of two production shifts at its Smyrna plant by this month but now intends to maintain both shifts due to the updated strategy.
On Thursday, Nissan also announced it would stop taking new U.S. orders for two Mexico-produced Infiniti SUVs, following earlier tariff-related announcements. The decision marks a significant pullback from operations at a joint venture plant affected by the tariffs.
In 2024, Nissan sold approximately 920,000 vehicles in the U.S., with around 16% imported from Japan. The proposed production changes may impact Japanese suppliers that support Nissan’s domestic manufacturing operations.
As automakers face growing uncertainty from global trade disputes, Nissan’s strategy reflects a broader industry trend toward localizing production to reduce exposure to tariffs and supply chain disruptions. The shift could strengthen Nissan’s U.S. manufacturing footprint while easing the financial strain of international trade barriers.


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



